Pyxis Oncology, Inc.
Prognozy (mln)
| Okres |
2024-12-31 |
2025-12-31 |
2026-12-31 |
2027-12-31 |
2028-12-31 |
2029-12-31 |
| Przychód (średnia) |
16.11 |
0.40 |
6.25 |
9.29 |
24.50 |
65.67 |
| Przychód Δ r/r |
0.00% |
-97.52% |
1462.50% |
48.63% |
163.74% |
168.03% |
| Przychód (min) |
16.06 |
0.40 |
6.25 |
9.29 |
24.50 |
65.67 |
| Przychód (max) |
16.21 |
0.40 |
6.25 |
9.29 |
24.50 |
65.67 |
| EBITDA (średnia) |
9.66 |
0.24 |
3.75 |
5.57 |
14.70 |
39.40 |
| EBIT (średnia) |
9.66 |
0.24 |
3.75 |
5.57 |
14.70 |
39.40 |
| EBIT % |
60.00% |
60.00% |
60.00% |
60.00% |
60.00% |
60.00% |
| Zysk netto (średni) |
-63.50 |
-80.46 |
-65.66 |
-70.55 |
-61.22 |
-39.01 |
| Zysk netto % |
-394.23% |
-20115.13% |
-1050.50% |
-759.45% |
-249.88% |
-59.41% |
| EPS (średnia) |
-1.09 |
-1.38 |
-1.20 |
-1.23 |
-1.05 |
-0.67 |
| Liczba analityków (Przychody) |
5 |
4 |
6 |
6 |
2 |
5 |
| Liczba analityków (EPS) |
5 |
6 |
5 |
4 |
3 |
2 |
| symbol |
PYXS |
PYXS |
PYXS |
PYXS |
PYXS |
PYXS |